Carlos A. Pacheco, M.D.
NPI 1104824127ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Maitland, FL
Opted out of Medicare from January 2024 to January 2028. Internal Medicine, Endocrinology, Diabetes & Metabolism (M.D.) in Maitland, Florida, licensed in FL, with an NPI issued in July 2005. Part D covered 2,911 prescriptions written in 2024, 41% of them generic. Sanofi-Aventis U.S. LLC was the largest of 26 companies reporting payments in 2025, $2,575 in all, mostly food and beverage.
Overview
| NPI | 1104824127 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | M.D. |
| Sole proprietor | No |
| NPI issued | Jul 13, 2005 |
| Last updated in NPPES | Jul 16, 2013 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | ME53974 | FL |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Jan 1, 2024 – Jan 1, 2028 |
| Can order and refer | Yes |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Part D prescriptions in 2024
| Prescriptions (claims) | 2,911 · 7,484 30-day fills |
|---|---|
| Patients | 578 |
| Total drug cost | $1,103,967 |
| Generic share | 41% of claims |
Industry payments (Open Payments)
- 2025$2,575 · 78 payments from 26 companies
- 2024$2,025 · 82 payments from 19 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Sanofi-Aventis U.S. LLC | $469.67 | 6 |
| Novo Nordisk Inc | $375.56 | 11 |
| Cequr Corporation | $188.76 | 3 |
| Beta Bionics, Inc. | $184.57 | 3 |
| Lilly USA, LLC | $178.90 | 7 |
What the 2025 payments were for
- Food and Beverage$2,575 · 78 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other endocrinologists in Maitland
- 1235137167
- 1619975638
- 1912337924
- 1174064513
- 1275313843
- 1427043439